Corticosteroid Contraindications
Systemic corticosteroids have very few absolute contraindications—the primary absolute contraindication is active systemic infection (superficial or deep), fracture at the injection site, or presence of a prosthetic joint when considering local injection. 1 However, rather than true contraindications, corticosteroid therapy requires careful evaluation and management of multiple high-risk comorbidities before initiation.
Risk Assessment Framework Before Initiating Therapy
Before starting corticosteroids, you must evaluate and optimize the following comorbidities and risk factors 2:
High-Risk Conditions Requiring Pre-Treatment Optimization:
- Hypertension - must be controlled before starting therapy
- Diabetes mellitus - requires intensified monitoring and likely medication adjustment
- Peptic ulcer disease - especially critical if concurrent NSAID use planned
- Recent fractures - indicates high osteoporosis risk
- Cataract or glaucoma - requires ophthalmologic baseline and monitoring
- Chronic or active infections - must be treated or ruled out
- Dyslipidemia - will worsen with therapy
- Concurrent NSAID use - dramatically increases GI bleeding risk
Critical Clinical Context
The EULAR guidelines emphasize that these are not absolute contraindications but rather conditions requiring evaluation and treatment before glucocorticoid initiation 2. The distinction is crucial: you can still use corticosteroids in patients with diabetes or hypertension, but you must address these conditions first and monitor more intensively.
Life-Threatening Conditions Where Benefits Override Risks
Even in the presence of multiple risk factors, corticosteroid therapy is mandatory and life-saving in 3:
- Pemphigus
- Acute disseminated lupus erythematosus
- Severe exfoliative dermatitis
- Septic shock 4
- Severe community-acquired pneumonia 4
- Acute respiratory distress syndrome 4
In these scenarios, the mortality benefit far outweighs the risk of adverse effects.
Specific Contraindications by Route
For Intra-articular/Local Injections 1, 5:
- Superficial or deep infection (absolute)
- Fracture at injection site (absolute)
- Prosthetic joint (absolute)
- Overlying cellulitis
For Systemic Therapy:
- Active systemic fungal, bacterial, or viral infections (relative—treat infection first or use concurrently with antimicrobials)
- Live virus vaccination - avoid during therapy 6
Special Population Considerations
Pregnancy
Corticosteroids during pregnancy have no additional risk for mother and child (Level IB-III evidence) 2. This is actually reassuring—pregnancy is NOT a contraindication.
Immunocompromised Hosts
This population presents unique challenges as they were systematically excluded from landmark trials 7. Exercise extreme caution and consider infectious disease consultation, but immunocompromise itself is not an absolute contraindication if the underlying condition warrants treatment.
Common Clinical Pitfalls
Mistaking risk factors for contraindications: Diabetes, hypertension, and osteoporosis are manageable risks, not reasons to withhold necessary therapy 2
Failing to discuss risks upfront: You must inform patients about adverse effects before starting therapy and provide written information 2, 6
Not issuing a steroid card: For prolonged therapy, patients need documentation of their regimen 2
Ignoring chickenpox exposure risk: Patients on systemic corticosteroids have increased susceptibility to severe varicella infection 6
Stopping abruptly: Never discontinue suddenly—adrenal suppression occurs after >1 month of therapy 2
Practical Pre-Treatment Checklist
Before prescribing systemic corticosteroids:
- Screen for active infections (including tuberculosis if high risk)
- Check baseline blood pressure, glucose, lipids
- Assess fracture risk and bone density if prolonged use anticipated
- Document peptic ulcer history
- Ophthalmologic evaluation if pre-existing eye disease
- Verify vaccination status (give needed vaccines before starting if possible)
- Discuss risks and provide patient education materials 2, 6
The key principle: systemic corticosteroids have remarkably few absolute contraindications, but require comprehensive risk stratification and proactive management of comorbidities to minimize morbidity.